Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study

被引：3

作者：

Mohan, Meera ^{[1
]}

Shah, Nishi ^{[2
]}

Luan, Danny ^{[3
]}

Monge, Jorge ^{[4
]}

Forsberg, Mark ^{[5
,6
]}

Bhatlapenumarthi, Vineel ^{[7
]}

Balev, Metodi ^{[8
]}

Patwari, Anannya ^{[9
]}

Cheruvalath, Heloise ^{[10
]}

Bhutani, Divaya ^{[11
]}

Thanendrarajan, Sharmilan ^{[12
]}

Dhakal, Binod ^{[13
]}

Zangari, Maurizio ^{[12
]}

Al Hadidi, Samer ^{[12
]}

Cooper, Dennis L. ^{[14
]}

Lentzsch, Suzanne ^{[15
]}

van Rhee, Frits ^{[12
]}

D'Souza, Anita ^{[16
]}

Szabo, Aniko ^{[9
]}

Schinke, Carolina ^{[17
]}

Chakraborty, Rajshekhar ^{[8
]}

机构：

[1] Med Coll Wisconsin, Dept Med, BMT & Cellular Therapy Program, Milwaukee, WI USA

[2] Montefiore Med Ctr, Oncol, Albert Einstein Coll Med, Bronx, NY USA

[3] Newyork Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA

[4] Weill Cornell Med, New York, NY USA

[5] Montefiore Med Ctr, Dept Oncol, Bronx, NY USA

[6] Albert Einstein Coll Med, Bronx, NY USA

[7] Med Coll Wisconsin, Dept Hematol Oncol, Milwaukee, WI USA

[8] Columbia Univ, Irving Med Ctr, New York, NY USA

[9] Med Coll Wisconsin, Milwaukee, WI USA

[10] Med Coll Wisconsin, Sch Med, Milwaukee, WI USA

[11] Columbia Univ, Coll Phys & Surg, New York, NY USA

[12] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Myeloma Ctr, Little Rock, AR USA

[13] Med Coll Wisconsin, Wauwatosa, WI USA

[14] Montefiore Med Ctr, New York, NY USA

[15] Columbia Univ, Irving Med Ctr, New York Presbyterian, New York, NY USA

[16] Med Coll Wisconsin Inc, Milwaukee, WI USA

[17] Myeloma Inst, Little Rock, AR USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-174875

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[31] Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
Huang, Shang-Yi
Chen, Tsai-Yun
Kuo, Ching-Yuan
Chen, Yeu-Chin
Lin, Sheng-Fung
Chang, Ming-Chih
Lv, Xinzhu
Yang, Betty
Chang, Cheng-Shyong
ONCOLOGY REVIEWS, 2019, 13 (01) : 15 - 22
[32] Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Experience
Hultcrantz, Malin
Orozco, Jennifer
Peterson, Tim J.
Derkach, Andriy
Hassoun, Hani
Korde, Neha
Lu, Sydney X.
Mailankody, Sham
Patel, Dhwani
Shah, Urvi A.
Tan, Carlyn
Maclachlan, Kylee H.
Chung, David J.
Landau, Heather J.
Shah, Gunjan L.
Lahoud, Oscar B.
Scordo, Michael
Landgren, Ola
Giralt, Sergio
Lesokhin, Alexander
BLOOD, 2021, 138
[33] Real-World Practice Patterns with Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma
Harvey, R. Donald
Cong, Ze
Werther, Winifred
Lethen, Jan L.
Lonial, Sagar
BLOOD, 2014, 124 (21)
[34] Real-World Treatment of Patients With Relapsed/Refractory Myeloma
Ntanasis-Stathopoulos, Ioannis
Gavriatopoulou, Maria
Terpos, Evangelos
Dimopoulos, Meletios A.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06): : 379 - 385
[35] Belantamab Mafodotin (Belamaf) for Relapsed/Refractory Multiple Myeloma (RRMM): A Real-World Observational Study
Hultcrantz, Malin
Kleinman, David
Vij, Ravi
Escalante, Fernando
Kotowsky, Nirali
Bitetti, Jacopo
Mackay, Christine
Boytsov, Natalie
Camadoo-O'Byrne, Leena
Germain, Guillaume
Duh, Mei Sheng
Laliberte, Francois
Mahendran, Malena
Urosevic, Ana
Lee, Hans C.
BLOOD, 2022, 140 : 10124 - 10126
[36] Bortezomib retreatment for relapsed and refractory multiple myeloma in real-world clinical practice
Hulin, Cyrille
de la Rubia, Javier
Dimopoulos, Meletios A.
Terpos, Evangelos
Katodritou, Eirini
Hungria, Vania
De Samblanx, Hadewijch
Stoppa, Anne-Marie
Aagesen, Jesper
Sargin, Deniz
Sioni, Anastasia
Belch, Andrew
Diels, Joris
Olie, Robert A.
Robinson, Don, Jr.
Potamianou, Anna
van de Velde, Helgi
Delforge, Michel
HEALTH SCIENCE REPORTS, 2019, 2 (01)
[37] A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study
Rios-Tamayo, Rafael
Soler, Juan Alfons
Garcia-Sanchez, Ricarda
Persona, Ernesto Perez
Arnao, Mario
Garcia-Guinon, Antoni
Domingo, Abel
Gonzalez-Pardo, Miriam
de la Rubia, Javier
Mateos, Maria Victoria
HEMATOLOGY, 2023, 28 (01)
[38] Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: a multi-center retrospective study
Shragai, Tamir
Magen, Hila
Lavi, Noa
Gatt, Moshe
Trestman, Svetlana
Zektser, Miri
Ganzel, Chezi
Jarchowsky, Osant
Berger, Tamar
Tadmor, Tamar
Leiba, Merav
Hertzog-Zarfaty, Katrin
Horowitz, Netanel
Shapira, Michael
Varssano, David
Berger, Yoav
Frenkel, Shahar
Krauthammer, Mark
Avivi, Irit
Luttwak, Efrat
Cohen, Yael
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S98 - S98
[39] The efficacy and safety of pomalidomide in relapsed/refractory multiple myeloma in a "real-world" study: Polish Myeloma Group experience
Charlinski, Grzegorz
Grzasko, Norbert
Jurczyszyn, Artur
Janczarski, Mariusz
Szeremet, Agnieszka
Waszczuk-Gajda, Anna
Bernatowicz, Pawel
Swiderska, Alina
Guzicka-Kazimierczak, Renata
Lech-Maranda, Ewa
Szczepaniak, Andrzej
Wichary, Ryszard
Dmoszynska, Anna
EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (03) : 354 - 361
[40] Update Analysis of Central Nervous System Multiple Myeloma Prognosis and Survival: A Real-World Multi-Institutional Study of the Greek Myeloma Study Group
Katodritou, Eirini
Dalampira, Dimitra
Delimpasi, Sosana
Ntanasis-Stathopoulos, Ioannis
Karaolidou, Frini
Gkioka, Annita Ioanna
Labropoulou, Vasiliki
Spanoudakis, Emmanouil
Triantafyllou, Theodora
Kotsopoulou, Maria
Michalis, Eyrydiki
Vadikolia, Chrysanthi
Papadopoulou, Theodosia
Sevastoudi, Aggeliki
Michael, Michael
Daiou, Aikaterini
Pentidou, Aikaterini
Kostopoulos, Ioannis V.
Palaska, Vasiliki
Gavriatopoulou, Maria
Kyrtsonis, Marie-Christine
Verrou, Evgenia
Kastritis, Efstathios
Dimopoulos, Meletios A.
Terpos, Evangelos
BLOOD, 2023, 142

← 1 2 3 4 5 →